N. Franke

1.6k total citations
40 papers, 1.1k citations indexed

About

N. Franke is a scholar working on Molecular Biology, Hematology and Surgery. According to data from OpenAlex, N. Franke has authored 40 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Molecular Biology, 10 papers in Hematology and 7 papers in Surgery. Recurrent topics in N. Franke's work include Ubiquitin and proteasome pathways (12 papers), Protein Degradation and Inhibitors (11 papers) and Multiple Myeloma Research and Treatments (8 papers). N. Franke is often cited by papers focused on Ubiquitin and proteasome pathways (12 papers), Protein Degradation and Inhibitors (11 papers) and Multiple Myeloma Research and Treatments (8 papers). N. Franke collaborates with scholars based in Netherlands, Germany and United States. N. Franke's co-authors include Gertjan J.L. Kaspers, Gerrit Jansen, Jacqueline Cloos, Yehuda G. Assaraf, Ina van Zantwijk, Bauke Ylstra, Godefridus J. Peters, George L. Scheffer, Rik J. Scheper and Joost W van der Heijden and has published in prestigious journals such as Blood, The Journal of Immunology and Oncogene.

In The Last Decade

N. Franke

37 papers receiving 1.1k citations

Peers

N. Franke

HEMAT

ONCOL

IMMUN

Sailaja Narravula United States

Kenneth Langlands United Kingdom

Amélie Montel‐Hagen United States

David A. Wilcox United States

César Sanz-Rodrı́guez Spain

Yang Du China

Gabriele Zuchtriegel Germany

Toshioki Sawaki Japan

N. Kubota Japan

Takafumi Kawanami Japan

Sailaja Narravula United States

N. Franke

823 ×1.1

495 ×1.6

HEMAT

124 ×0.5

ONCOL

215 ×1.4

IMMUN

55 ×0.4

Citations per year, relative to N. Franke N. Franke (= 1×) peers Sailaja Narravula

Countries citing papers authored by N. Franke

Since Specialization

Citations

This map shows the geographic impact of N. Franke's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by N. Franke with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites N. Franke more than expected).

Fields of papers citing papers by N. Franke

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by N. Franke. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by N. Franke. The network helps show where N. Franke may publish in the future.

Co-authorship network of co-authors of N. Franke

This figure shows the co-authorship network connecting the top 25 collaborators of N. Franke. A scholar is included among the top collaborators of N. Franke based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with N. Franke. N. Franke is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Metselaar, Dennis S., Michaël H. Meel, Aimée du Chatinier, et al.. (2024). Gemcitabine therapeutically disrupts essential SIRT1-mediated p53 repression in atypical teratoid/rhabdoid tumors. Cell Reports Medicine. 5(9). 101700–101700. 3 indexed citations

Williams, Justin, Femke Ringnalda, Natalia Moreno, et al.. (2023). Atypical teratoid/rhabdoid tumoroids reveal subgroup-specific drug vulnerabilities. Oncogene. 42(20). 1661–1671. 15 indexed citations

Cloos, Jacqueline, N. Franke, Johan van Meerloo, et al.. (2017). (Immuno)proteasomes as therapeutic target in acute leukemia. Cancer and Metastasis Reviews. 36(4). 599–615. 27 indexed citations

Franke, N., Gertjan J.L. Kaspers, Yehuda G. Assaraf, et al.. (2016). Exocytosis of polyubiquitinated proteins in bortezomib-resistant leukemia cells: a role for MARCKS in acquired resistance to proteasome inhibitors. Oncotarget. 7(46). 74779–74796. 17 indexed citations

Niewerth, Denise, N. Franke, Gerrit Jansen, et al.. (2013). Higher ratio immune versus constitutive proteasome level as novel indicator of sensitivity of pediatric acute leukemia cells to proteasome inhibitors. Haematologica. 98(12). 1896–1904. 54 indexed citations

Niewerth, Denise, N. Franke, Gerrit Jansen, et al.. (2012). Interferon-γ-Induced Upregulation of Immunoproteasome Subunit Assembly Overcomes Bortezomib Resistance of Leukemia Cell Lines Harbouring Bortezomib-Induced Mutations in Constitutive PSMB5. Blood. 120(21). 1346–1346. 1 indexed citations

Franke, N., Denise Niewerth, Yehuda G. Assaraf, et al.. (2011). Impaired bortezomib binding to mutant β5 subunit of the proteasome is the underlying basis for bortezomib resistance in leukemia cells. Leukemia. 26(4). 757–768. 137 indexed citations

Beumer, Jan H., N. Franke, Tessa Buckle, et al.. (2009). Disposition and toxicity of trabectedin (ET-743) in wild-type and mdr1 gene (P-gp) knock-out mice. Investigational New Drugs. 28(2). 145–155. 11 indexed citations

Franke, N., Gerrit Jansen, Ina van Zantwijk, & B.A.C. Dijkmans. (2007). Glucocorticoid-resistance in childhood leukaemia. 1 indexed citations

10.

Franke, N., Ruud Oerlemans, Sonja Zweegman, et al.. (2007). Molecular Mechanisms of Bortezomib Resistance in Acute Lymphoblastic Leukemia Cells in Comparison with Multiple Myeloma Cells.. Blood. 110(11). 3469–3469. 2 indexed citations

11.

Beumer, Jan H., Tessa Buckle, Mariët Ouwehand, et al.. (2006). Trabectedin (ET-743, Yondelis™) is a substrate for P-glycoprotein, but only high expression of P-glycoprotein confers the multidrug resistance phenotype. Investigational New Drugs. 25(1). 1–7. 16 indexed citations

12.

Berg, Timo K. van den, Henk Honing, N. Franke, et al.. (2004). LacdiNAc-Glycans Constitute a Parasite Pattern for Galectin-3-Mediated Immune Recognition. The Journal of Immunology. 173(3). 1902–1907. 146 indexed citations

13.

Hentschel, Roland, Thomas Brune, N. Franke, Erik Harms, & Gerhard Jorch. (2002). Sequential changes in compliance and resistance after bolus administration or slow infusion of surfactant in preterm infants. Intensive Care Medicine. 28(5). 622–628. 19 indexed citations

14.

Herrmann, Ralf, Volker Straub, Martina Blank, et al.. (2000). Dissociation of the dystroglycan complex in caveolin-3-deficient limb girdle muscular dystrophy. Human Molecular Genetics. 9(15). 2335–2340. 115 indexed citations

15.

Taeger, K., et al.. (1988). PULMONARY KINETICS OF FENTANYL AND ALFENTANIL IN SURGICAL PATIENTS. British Journal of Anaesthesia. 61(4). 425–434. 37 indexed citations

16.

Endrich, B, N. Franke, Klaus Peter, & K. Meßmer. (1987). Induced Hypotension: Action of Sodium Nitroprusside and Nitroglycerin on the Microcirculation. Anesthesiology. 66(5). 605–613. 37 indexed citations

17.

Franke, N. & B Endrich. (1983). [Effects of halothane and enflurane on the microcirculation].. PubMed. 18(6). 285–90. 3 indexed citations

18.

Franke, N. & B Endrich. (1983). Einfluß von Halothan und Enflurane auf die Mikrozirkulation. AINS - Anästhesiologie · Intensivmedizin · Notfallmedizin · Schmerztherapie. 18(6). 285–290. 1 indexed citations

19.

Überfuhr, P, Bruno Reichart, Armin Welz, et al.. (1982). Bericht über eine erfolgreiche orthotope Herztransplantation in Deutschland. Journal of Molecular Medicine. 60(23). 1435–1442. 3 indexed citations

20.

Reichart, Bruno, E. Alt, B. M. Kemkes, et al.. (1981). Treatment of acute left heart failure using dobutamine and intraaortic counterpulsation. Intensive Care Medicine. 7(3). 133–138. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact